Presence of HPV type 6 in dysplasia and carcinoma arising from recurrent respiratory papillomatosis

Head and Neck

Volumn 31, Issue 8, 2009, Pages 1095-1101

  Jeong, Woo Jin ^a   Park, Seok Woo ^a   Shin, Miwha ^a   You, Jeong Lee ^a   Yoon, Kyung Jeon ^a   Young, Ho Jung ^a   Hah, J Hun ^a   Kwon, Tack Kyun ^a   Song, Yong Sang ^a   Kwang, Hyun Kim ^a   Sung, Myung Whun ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Carcinoma; Human papillomavirus; Malignant transformation; Recurrent respiratory papillomatosis; Tumor virus infections

Indexed keywords

ANTINEOPLASTIC AGENT; KI 67 ANTIGEN; PRB PROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CARCINOGENESIS; CASE REPORT; CONTROLLED STUDY; DISEASE SEVERITY; DNA MICROARRAY; DYSPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LASER CAPTURE MICRODISSECTION; LUNG METASTASIS; MALE; MALIGNANT TRANSFORMATION; MICROSURGERY; PAPILLOMATOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT RESPIRATORY PAPILLOMATOSIS; SQUAMOUS CELL CARCINOMA; TRACHEA RESECTION; VIRUS IDENTIFICATION; VIRUS TYPING;

ADULT; BIOPSY, NEEDLE; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; HUMAN PAPILLOMAVIRUS 6; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAPILLOMA; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SAMPLING STUDIES;

EID: 67650439327     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20998     Document Type: Article

References (25)

1. Hartnick CJ, MacCallum PL. Carcinoma in children with recurrent respiratory papillomas: an update. Curr Opin Otolaryngol Head Neck Surg 2001;9:374-376. (Pubitemid 33152587)
2. Fehrmann F, Laimins LA. Human papillomavirus type 31 life cycle: methods for study using tissue culture models. Methods Mol Biol 2005;292:317-330.
3. Gerein V, Rastorguev E, Gerein J, Draf W, Schirren J. Incidence, age at onset, and potential reasons of malignant transformation in recurrent respiratory papillomatosis patients: 20 years experience. Otolaryngol Head Neck Surg 2005;132:392-394. (Pubitemid 40326688)
4. Doyle DJ, Henderson LA, LeJeune FE Jr, Miller RH. Changes in human papillomavirus typing of recurrent respiratory papillomatosis progressing to malignant neoplasm. Arch Otolaryngol Head Neck Surg 1994;120: 1273-1276. (Pubitemid 24345772)
5. Lie ES, Karlsen F, Holm R. Presence of human papillomavirus in squamous cell laryngeal carcinomas. A study of thirty-nine cases using polymerase chain reaction and in situ hybridization. Acta Otolaryngol 1996;116:900-905.
6. Venuti A, Manni V, Morello R, De Marco F, Marzetti F, Marcante ML. Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J Med Virol 2000;60:396-402. (Pubitemid 30127310)
7. Lee SA, Kang D, Seo SS, et al. Multiple HPV infection in cervical cancer screened by HPVDNAChip. Cancer Lett 2003;198:187-192. (Pubitemid 37303950)
8. Dedo HH, Yu KC. CO(2) laser treatment in 244 patients with respiratory papillomas. Laryngoscope 2001;111: 1639-1644.
9. Klozar J, Taudy M, Betka J, Kana R. Laryngeal papilloma- precancerous condition? Acta Otolaryngol Suppl 1997;527:100-102.
10. Moore CE, Wiatrak BJ, McClatchey KD, et al. High-risk human papillomavirus types and squamous cell carcinoma in patients with respiratory papillomas. Otolaryngol Head Neck Surg 1999;120:698-705. (Pubitemid 29226257)
11. Reidy PM, Dedo HH, Rabah R, et al. Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer. Laryngoscope 2004;114: 1906-1909. (Pubitemid 39539845)
12. Go C, Schwartz MR, Donovan DT. Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 overexpression. Ann Otol Rhinol Laryngol 2003;112:298-302. (Pubitemid 36438024)
13. Lele SM, Pou AM, Ventura K, Gatalica Z, Payne D. Molecular events in the progression of recurrent respiratory papillomatosis to carcinoma. Arch Pathol Lab Med 2002;126:1184-1188. (Pubitemid 36240253)
14. Gupta D, Holden J, Layfield L. Topoisomerase alpha II, retinoblastoma gene product, and p 53: potential relationships with aggressive behavior and malignant transformation in recurrent respiratory papillomatosis. Appl Immunohistochem Mol Morphol 2001;9:86-91.
15. Rady PL, Schnadig VJ, Weiss RL, Hughes TK, Tyring SK. Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p 53. Laryngoscope 1998;108:735-740.
16. Lin KY, Westra WH, Kashima HK, Mounts P, Wu TC. Coinfection of HPV-11 and HPV-16 in a case of laryngeal squamous papillomas with severe dysplasia. Laryngoscope 1997;107:942-947. (Pubitemid 27284323)
17. Sakakura A, Yamamoto Y, Takasaki T, Makimoto K, Nakamura M, Takahashi H. Recurrent laryngeal papillomatosis developing into laryngeal carcinoma with human papilloma virus (HPV) type 18: a case report. J Laryngol Otol 1996;110:75-77. (Pubitemid 26036610)
18. Pou AM, Rimell FL, Jordan JA, et al. Adult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis. Ann Otol Rhinol Laryngol 1995;104(10Part1):758-762.
19. Guillou L, Sahli R, Chaubert P, Monnier P, Cuttat JF, Costa J. Squamous cell carcinoma of the lung in a nonsmoking, nonirradiated patient with juvenile laryngotracheal papillomatosis. Evidence of human papillomavirus- 11 DNA in both carcinoma and papillomas. Am J Surg Pathol 1991;15:891-898.
20. Lindeberg H, Syrjanen S, Karja J, Syrjanen K. Human papillomavirus type 11 DNA in squamous cell carcinomas and pre-existing multiple laryngeal papillomas. Acta Otolaryngol 1989;107:141-149. (Pubitemid 19035865)
21. Zarod AP, Rutherford JD, Corbitt G. Malignant progression of laryngeal papilloma associated with human papilloma virus type 6 (HPV-6) DNA. J Clin Pathol 1988; 41:280-283. (Pubitemid 18091044)
22. Byrne JC, Tsao MS, Fraser RS, Howley PM. Human papillomavirus-11 DNA in a patient with chronic laryngotracheobronchial papillomatosis and metastatic squamous- cell carcinoma of the lung. N Engl J Med 1987;317:873-878. (Pubitemid 17160540)
23. Havre PA, Yuan J, Hedrick L, Cho KR, Glazer PM. p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res 1995;55:4420-4424.
24. Gerdes J, Li L, Schlueter C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation- associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867-873.
25. Stern Y, Heffelfinger SC, Walner DL, Cotton RT. Expression of Ki-67, tumor suppressor proteins, growth factor, and growth factor receptor in juvenile respiratory papillomatosis: Ki-67 and p53 as predictors of aggressive disease. Otolaryngol Head Neck Surg 2000;122:378-386. (Pubitemid 30155318)